New gut implant aims to tackle diabetes and obesity without surgery
Disease control
Not yet recruiting
This study tests a temporary device placed in the upper small intestine to help control type 2 diabetes and obesity. The implant stays for 6 months and is then removed. Researchers will check if it lowers blood sugar (HbA1c), helps with weight loss, and improves liver health in p…
Phase: NA • Sponsor: Trans-Duodenal Concepts GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC